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Abstract
Background: An increased interest is observed in broadening community pharmacists’ role in public health. To
date, little information has been gathered in Canada on community pharmacists’ perceptions of their role in health
promotion and prevention; however, such data are essential to the development of public-health programs in
community pharmacy. A cross-sectional study was therefore conducted to explore the perceptions of community
pharmacists in urban and semi-urban areas regarding their ideal and actual levels of involvement in providing
health-promotion and prevention services and the barriers to such involvement.
Methods: Using a five-step modified Dillman’s tailored design method, a questionnaire with 28 multiple-choice or
open-ended questions (11 pages plus a cover letter) was mailed to a random sample of 1,250 pharmacists out of 1,887
community pharmacists practicing in Montreal (Quebec, Canada) and surrounding areas. It included questions on
pharmacists’ ideal level of involvement in providing health-promotion and preventive services; which services were
actually offered in their pharmacy, the employees involved, the frequency, and duration of the services; the barriers to
the provision of these services in community pharmacy; their opinion regarding the most appropriate health
professionals to provide them; and the characteristics of pharmacists, pharmacies and their clientele.
Results: In all, 571 out of 1,234 (46.3%) eligible community pharmacists completed and returned the questionnaire.
Most believed they should be very involved in health promotion and prevention, particularly in smoking cessation
(84.3%); screening for hypertension (81.8%), diabetes (76.0%) and dyslipidemia (56.9%); and sexual health (61.7% to
89.1%); however, fewer respondents reported actually being very involved in providing such services (5.7% [lifestyle,
including smoking cessation], 44.5%, 34.8%, 6.5% and 19.3%, respectively). The main barriers to the provision of
these services in current practice were lack of: time (86.1%), coordination with other health care professionals
(61.1%), staff or resources (57.2%), financial compensation (50.8%), and clinical tools (45.5%).
Conclusions: Although community pharmacists think they should play a significant role in health promotion and
prevention, they recognize a wide gap between their ideal and actual levels of involvement. The efficient
integration of primary-care pharmacists and pharmacies into public health cannot be envisioned without
addressing important organizational barriers.
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Recently, there has been an increased interest in broaden-
ing community pharmacists’ functions toward playing a
greater role in public health [1]. Community pharmacies
are often considered an ideal site for credible counseling
for a large segment of the population because pharmacists
are accessible, have frequent contact with the public, have
extended opening hours, and are widely distributed geo-
graphically [1-3]. Given the increasing stresses on the
health care system due to an aging population and the
consequent rise in the prevalence and incidence of chronic
diseases, the shift toward a wider public-health role for
pharmacists should be accentuated.
Health-promotion and preventive services refer to public
health services, which relate to the improvement of the
general health of the population through interventions
aiming at promoting health and wellbeing (e.g. nutrition,
physical activity), preventing diseases (e.g. smoking cessa-
tion, immunization, travel health), identifying ill indivi-
duals (e.g. screening and case finding) and maintaining
health of those with chronic conditions (e.g. diabetes,
hypertension) [4,5]. Public health interventions act on fac-
tors influencing the health of the population as a whole or
subgroups of this population rather than separate indivi-
duals, and generally take place before the onset of health
problems [4]. Throughout this paper, clinical services such
as medication reviews were not considered as health-pro-
motion or preventive services since they target specific
individuals.
Studies from many countries have demonstrated the
benefits of pharmacy services on a wide range of impor-
tant public-health issues [5]: notably in smoking cessation
[6,7], diabetes [8,9], hypertension [9,10], dyslipidemia [9],
contraception [11], osteoporosis [12-14], and immuniza-
tion [15,16]. A recent Cochrane review confirmed the
importance of the pharmacist’s role in therapeutic man-
agement and patient counseling [17]. The broader involve-
ment of community pharmacists is thus deemed a
valuable option in addressing several public-health issues.
In some countries, such as the United Kingdom, pharma-
cists are integrated into public-health programs [18]. In
contrast, Quebec’s public-health program does not stress
the role of pharmacists as primary-care providers in this
area [4].
To date, little information has been gathered in Canada
on community pharmacists’ perceptions of their role in
health promotion and prevention. However, such data
are essential to the development of public-health pro-
grams in community pharmacy. In this study, we docu-
mented the perceptions of community pharmacists in
urban and semi-urban areas regarding their ideal and
actual levels of involvement in the provision of health-
promotion and preventive services, as well as the barriers
that limit their involvement.
Results
Of the 1,250 pharmacists selected, eight did not work in
community pharmacy. Twelve questionnaires were
returned undelivered because the address was wrong. Fol-
lowing the first questionnaire mailing, we were informed
that one pharmacist had retired, one was on maternity
leave, and one declined (verbally) to take part. Ultimately,
577 completed questionnaires were returned. However, six
were returned by non-eligible pharmacists (four did not
work in community pharmacy, and two were not working
in a traditional community pharmacy), for a total of 571
questionnaires returned out of 1,234 eligible pharmacists
(response rate: 46.3%). More specifically, 249 question-
naires (43.6%) were received after the first questionnaire
mailing, 114 (20.0%) after the postcard mailing, 149
(26.1%) after the second questionnaire mailing, and 59
(10.3%) after the third questionnaire mailing. The response
rates for individual questions ranged from 87% to 100%,
and 99% of questions had a response rate over 90%.
As reported in Table 1, the respondents were in majority
women (63.2%), were staff pharmacists (65.3%), and
reported having completed a mean 31 hours of continuing
education during the past year. Their pharmacies were
associated with a chain or a corporate banner (80.4%) and/
or adjacent to a medical clinic (28.7%). The most prevalent
clienteles were elderly patients and families of average to
high socio-economic status. Furthermore, 53.5% of phar-
macists reported that a nurse was present in the pharmacy
for a mean 47 hours per month. Nutritionists (69 pharma-
cists) and naturopaths (11 pharmacists) were among other
common health professionals employed in the pharmacy.
Based on information from the Ordre des pharmaciens du
Québec (OPQ), our respondents were similar to commu-
nity pharmacists working in Quebec in terms of sex
(62.4% women in OPQ) and pharmacist status (63.9% staff
pharmacists in OPQ).
As Table 2 shows, most respondents believed they
should be either “very involved” or “involved” in providing
all health-promotion and preventive services. The majority
reported they should ideally be “very involved” in smoking
cessation (84.3%); screening for hypertension (81.8%), dia-
betes (76.0%) and dyslipidemia (56.9%); and sexual health
(61.7% to 89.1%). Most considered they should be
“involved” in providing information and counseling about
physical activity (71.1%), healthy eating (68.8%), weight
management (63.4%), and alcohol consumption (63.8%).
In contrast, 54.3% and 28.5% of pharmacists, respectively,
considered they should have “little involvement” or “no
involvement at all” in counseling on dental health and
screening for suicide risk. The proportion of respondents
who reported their community pharmacy as being actually
“very involved” in each service was 5.7% for lifestyle-
related activities, 44.5% for screening for hypertension,
34.8% for screening for diabetes, 6.5% for screening for
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Characteristics Total (n = 571)
Characteristics of pharmacists
Sex, n (%)
Men 210 (36.8)
Women 361 (63.2)
Practice region, n (%)
Montreal 184 (32.2)
Laval 51 (8.9)
Laurentides 75 (13.1)
Lanaudière 59 (10.3)
Montérégie 149 (26.1)
Estrie 30 (5.3)
Outaouais 23 (4.0)
Years since graduation, n (%)
≤ 10 years 230 (40.7)
11-20 years 135 (23.9)
21-30 years 106 (18.8)
≥ 31 years 94 (16.6)
Pharmacist status, n (%)
Owner pharmacist–single owner 78 (13.7)
Owner pharmacist–owner partner 82 (14.4)
Staff pharmacist 371 (65.3)
Replacement pharmacist 27 (4.8)
Staff and relief pharmacist 10 (1.8)
Hours worked per week, mean (SD
a) 33.6 (9.9)
Hours of continuing education during past year, mean (SD) 31.2 (37.3)
Private consultations in pharmacy privacy area per week, mean (SD) 22.0 (47.5)
Characteristics of pharmacies
Type of pharmacy, n (%)
b
Pharmacy adjacent to a medical clinic 163 (28.7)
Pharmacy associated with a chain or corporate banner 456 (80.4)
Independent pharmacy 16 (2.8)
Pharmacy associated with a supermarket or superstore 39 (6.9)
Pharmacy in a retirement home 21 (3.7)
Prescriptions filled per day, n (%)
< 250 prescriptions 147 (25.9)
250 to 500 prescriptions 197 (34.7)
> 500 prescriptions 224 (39.4)
Characteristics of most prevalent patients at the pharmacy, n(%)
b
Adults (18-49 years) 44 (8.1)
Older adults (50-65 years) 33 (6.1)
Elderly patients (> 65 years) 347 (63.9)
Young families 73 (13.4)
Families 159 (29.3)
All ages (various) 57 (10.5)
Other
c 86 (15.8)
Low to average socio-economic status 143 (26.3)
Average to high socio-economic status 273 (50.3)
High socio-economic status 43 (7.9)
Availability of other health professionals in the pharmacy, n(%)
b
Nurse 289 (53.5)
Nutritionist 69 (12.8)
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Page 3 of 11dyslipidemia and 19.3% for sexual health. Most respon-
dents reported their pharmacy as being either “involved”
or “little involved” in lifestyle-related activities (84.5%),
screening for dyslipidemia (57.8%), sexual health (74.5%)
and infectious diseases and immunization (72.4%). Most
appropriate primary-care providers for preventive counsel-
ing or screening were primary-care physicians, community
pharmacists and nurses. They also deemed kinesiologists,
nutritionists and physiotherapists well placed to offer life-
style-related services.
As Table 3 shows, the majority of respondents identified
the pharmacist as the main provider of health-promotion
and preventive services in their pharmacy, though nurses
and technical assistants were also frequently cited. Most
pharmacists reported that preventive services are given a
“few times per week” or a “few times per month” regard-
ing: lifestyle (69.5%), screening for hypertension (96.6%),
screening for diabetes (86.2%), and counseling on sexual
health (81.5%). Activities related to infectious diseases and
immunization were reported for the most part to take
place a “few times per month” or a “few times per year”
(61.8%); 36.8% of respondents indicated that screening for
dyslipidemia never occurred. Consultations were reported
to last 10 minutes or less by most pharmacists. When
cases are detected during screening, most pharmacists said
the report is given to the patient only (67.4% for hyperten-
sion, 35.7% for dyslipidemia and 67.9% for diabetes); smal-
ler percentages said the report is given to both the patient
and the primary-care physician (33.5% for hypertension,
18.6% for dyslipidemia and 31.4% for diabetes).
Pharmacists were also asked to report the actual speci-
fic activities provided in their pharmacy. As indicated in
Table 4, the majority reported distributing written infor-
mation, providing personalized counseling when dispen-
sing medications and referring patients to external
resources. A large proportion of respondents said perso-
nalized follow-up for smoking cessation (44.5%), hyper-
tension (53.7%), diabetes (45.0%), and emergency oral
contraception (40.7%) were provided. Many pharmacists
provided no prevention activities regarding dental health
(29.3%), suicide risk (27.6%) or needle exchange (35.2%).
Many tasks were performed by a nurse or a nutritionist;
31 pharmacists thus reported that immunization was
conducted by a nurse. Several pharmacists reported hav-
ing a collective prescription for smoking cessation (39
pharmacists). Collective prescriptions enable authorized
professionals, usually pharmacists or nurses, to perform
certain tasks (for example, requesting laboratory tests
and adjusting medication dosage) without first having to
obtain an individual prescription from a physician [19].
As reported in Figure 1 the main barriers to providing
health-promotion and preventive services in their cur-
rent practice were lack of time (86.1%), lack of coordi-
nation with other health care professionals (61.1%), lack
of staff or resources (57.2%), lack of financial compensa-
tion (50.8%), and lack of clinical tools (45.5%). Six phar-
macists also indicated that their limited prescription
rights and the lack of collective prescriptions further
hampered their involvement in prevention.
aMore than one item could be checked.
bOther includes limited prescription rights for pharma-
cists and lack of collective prescriptions (n = 6); patients
a r eo f t e ni nar u s ha n dd o n ’th a v et i m ef o rp r e v e n t i o n
activities (n = 3); patients are not “open” to change (n =
3); too many technical tasks performed by the pharmacist
(n = 2); patients do not think of pharmacists for preven-
tion activities (n = 2); no standardized practice model (n =
2); lack of access to lab-test results and other patient infor-
mation (n = 2); pharmacists are overworked (n = 2);
nurses already perform some of these activities (n = 2);
lack of a closed office at the pharmacy (n = 1); low uptake
of pharmacist’s suggestions by physicians (n = 1); home
visits are expensive (n = 1); pharmacy owners not often
present at the pharmacy (n = 1); pharmacist shortage (n =
1); patients don’tl i k et ob e“criticized” about their lifestyle
(n = 1); relief pharmacists don’t know the pharmacy’s
patients very well (n = 1); the logistics of implementation
in general (n = 1); most of the pharmacy’s patients are not
regular patients (n = 1); lack of patient knowledge about
the benefits of prevention (n = 1); lack of tools for patients
Table 1 Characteristics of pharmacists and pharmacies (Continued)
Other
d 27 (5.0)
None 229 (42.4)
Hours per month of availability of other health professionals
in the pharmacy, mean (SD)
Nurse 47.4 (45.1)
Nutritionist 9.6 (6.5)
aSD standard deviation
bMore than one item could be checked.
cOther includes multicultural background (n = 23); workers/professionals (n = 13); children (n = 11); students (n = 9); patients with mental health problems (n =
8); rural background (n = 5); drug abuse (n = 5); patients from walk-in clinics or emergency rooms (n = 5); patients in long-term care facilities or nursing homes
(n = 4); tourists (n = 1); patients with organ transplant or dialysis (n = 1); and homosexuals (n = 1).
dOther includes naturopath (n = 11); breast-feeding counselor (n = 5); psychotherapist (n = 2); physiotherapist (n = 3); kinesiologist (n = 1); occupational therapist
(n = 1); massage therapist (n = 1); homeopath (n = 1); respiratory therapist (n = 1); and medical laboratory technologist (n = 1).
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Page 4 of 11Table 2 Ideal and actual levels of involvement of community pharmacists and most appropriate primary-care
providers for these services
Services Very involved n (%) Involved n (%) Little involved
n (%)
Not at all
involved n (%)
Ideal level of involvement
Lifestyle
Smoking cessation 478 (84.3) 85 (15.0) 4 (0.7) 0 (0)
Physical-activity promotion 94 (16.6) 403 (71.1) 68 (12.0) 2 (0.4)
Healthy eating 97 (17.2) 389 (68.8) 76 (13.5) 3 (0.5)
Weight management 128 (22.6) 359 (63.4) 75 (13.3) 4 (0.7)
Alcohol consumption 80 (14.1) 361 (63.8) 117 (20.7) 8 (1.4)
Dental health 27 (4.8) 231 (40.9) 281 (49.7) 26 (4.6)
Screening for:
Hypertension 464 (81.8) 96 (16.9) 7 (1.2) 0 (0)
Diabetes 431 (76.0) 127 (22.4) 9 (1.6) 0 (0)
Dyslipidemia 322 (56.9) 217 (38.3) 24 (4.2) 3 (0.5)
Risk of suicide 138 (24.4) 266 (47.1) 148 (26.2) 13 (2.3)
Sexual health
Emergency oral
contraception
505 (89.1) 58 (10.2) 3 (0.5) 1 (0.2)
Contraception 361 (63.7) 191 (33.7) 15 (2.6) 0 (0)
Counseling with partners when initiating treatment for
sexually transmitted diseases
350 (61.7) 194 (34.2) 21 (3.7) 2 (0.4)
Infectious diseases and immunization
Travel health 242 (42.8) 276 (48.8) 44 (7.8) 4 (0.7)
Needle-exchange programs 259 (45.8) 236 (41.8) 60 (10.6) 10 (1.8)
Immunization programs 163 (28.8) 313 (55.4) 82 (14.5) 7 (1.2)
Actual level of involvement
Lifestyle 32 (5.7) 232 (41.3) 243 (43.2) 55 (9.8)
Screening for hypertension 252 (44.5) 267 (47.2) 42 (7.4) 5 (0.9)
Screening for diabetes 198 (34.7) 255 (44.7) 100 (17.5) 17 (3.0)
Screening for dyslipidemia 37 (6.5) 150 (26.5) 177 (31.3) 202 (35.7)
Sexual health 109 (19.3) 274 (48.5) 147 (26.0) 35 (6.2)
Infectious diseases and immunization 48 (8.6) 189 (33.8) 216 (38.6) 107 (19.1)
Most appropriate providersa Primary care
physicians n (%)
Community
pharmacists n (%)
Nurses n (%) Other or nonen
n (%)
Lifestyle 327 (61.0) 379 (70.7) 354 (66.0) 166 (31.0)b
Screening for hypertension 399 (71.6) 520 (93.4) 429 (77.0) 22 (4.0)c
Screening for dyslipidemia 443 (83.1) 328 (61.5) 311 (58.3) 22(4.2)d
Screening for diabetes 419 (75.2) 494 (88.7) 442 (79.4) 27 (4.9)e
Sexual health 427 (77.6) 488 (88.7) 416 (75.6) 13 (2.3)f
Infectious diseases and immunization 371 (70.3) 313 (59.3) 450 (85.2) 17 (3.2)g
aMore than one item could be checked.
bOther includes kinesiologists (n = 48); nutritionists (n = 46); physiotherapists (n = 28); personal trainers in gyms (n = 12); dieticians (n = 12); occupational
therapists (n = 11); physical educators in schools (n = 10); all health professionals as multidisciplinary teams (n = 7); government (n = 5); public-health agencies
(n = 4); technical assistants (n = 2); local community service centre (CLSC) (n = 2); community support groups (n = 2); technicians (n = 2); recreation consultants
(n = 1); and pharmacy students (n = 1).
cOther includes technical assistants (n = 9); pharmacy students (n = 3); technicians (n = 3); the patient him/herself (n = 3); and CLSC (n = 2).
dOther includes nutritionists (n = 6); technical assistants (n = 1); CLSC (n = 1); dieticians (n = 1); and pharmacy students (n = 1).
eOther includes technical assistants (n = 8); nutritionists (n = 7); dieticians (n = 3); diabetes clinic (n = 3); CLSC (n = 2); physiotherapists (n = 1); technicians (n =
1); and the patient him/herself (n = 1).
fOther includes CLSC (n = 5); schools (n = 3); public-health agencies (n = 1); and sexologists (n = 1).
gOther includes travel clinic (n = 5); CLSC (n = 4); and public-health agencies (n = 1).
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Page 5 of 11(n = 1); pharmacy’s patients do not need preventive activ-
ities because they are already educated about the subject
(n = 1); lack of external resources to which patients can be
referred (n = 1); lack of budget for prevention activities at
the pharmacy (n = 1); lack of competent and stable staff (n
= 1); lack of interest by pharmacy owners (n = 1); and the
topic of prevention is very broad, so pharmacists provide
counseling on a little bit of everything but about nothing
in depth (n = 1).
Discussion
Community pharmacists in Montreal (Quebec, Canada)
and surrounding areas perceive their potential role in
health promotion and prevention as very significant, parti-
cularly in smoking cessation, screening for hypertension,
diabetes and dyslipidemia, and counseling on sexual
health. However, there is a wide gap between their ideal
and actual levels of involvement. Most pharmacists believe
they should be very involved in screening for hypertension
(81.8%), diabetes (76.0%) and dyslipidemia (56.9%); in fact,
though, only a minority is very involved (44.5%, 34.8% and
6.5%, respectively). Health-promotion and preventive ser-
vices in pharmacy are provided largely by pharmacists
and, to a lesser extent, by nurses and technical assistants.
In fact, more than half of surveyed pharmacists reported
that a nurse was present in their pharmacy. The services
Table 3 Characteristics of health-promotion and preventive services
Lifestyle Screening for
hypertension
Screening for
dyslipidemia
Screening for
diabetes
Sexual
health
Infectious diseases and
immunization
Main person(s) providing health-promotion and preventive services, n (%)
a
Pharmacist 432
(80.0)
497 (88.0) 202 (38.5) 462 (82.2) 522
(94.2)
348 (65.7)
Technical assistant 32 (5.9) 177 (31.3) 17 (3.2) 151 (26.9) 13 (2.3) 19 (3.6)
Nurse 143
(26.5)
215 (38.1) 197 (37.6) 241 (42.9) 58 (10.5) 9 (1.7)
Other 23 (4.3)
b 21 (3.7)
c 9 (1.7)
d 11 (2.0)
e 3 (0.5)
f 2 (0.4)
g
None 73 (13.5) 5 (0.9) 168 (32.1) 11 (2.0) 28 (5.1) 80 (15.1)
Frequency with which health-promotion and preventive services are provided, n (%)
a
Few times per week 203
(38.2)
465 (82.6) 96 (18.4) 301 (53.8) 249
(45.4)
116 (22.0)
Few times per month 166
(31.3)
79 (14.0) 133 (25.5) 181 (32.4) 198
(36.1)
171 (32.4)
Few times per year 94 (17.7) 21 (3.7) 107 (20.5) 77 (13.8) 63 (11.5) 155 (29.4)
Never 74 (13.9) 6 (1.1) 192 (36.8) 9 (1.6) 40 (7.3) 89 (16.9)
Duration of consultations related to health promotion and prevention, n (%)
a
Less than 5 minutes 255
(48.5)
157 (27.9) 71 (13.8) 97 (17.3) 128
(23.4)
149 (28.6)
5-10 minutes 153
(29.1)
324 (57.7) 151 (29.3) 301 (53.8) 279
(50.9)
180 (34.5)
11-15 minutes 51 (9.7) 80 (14.2) 85 (16.5) 139 (24.8) 99 (18.1) 85 (16.3)
More than 15 minutes 19 (3.6) 10 (1.8) 25 (4.9) 39 (7.0) 15 (2.7) 29 (5.6)
No consultation provided 72 (13.7) 7 (1.2) 188 (36.5) 12 (2.1) 32 (5.8) 87 (16.7)
Type(s) of follow-up for cases detected during screening, n (%)
a
Report given to patient only 0 (0) 372 (67.4) 178 (35.7) 374 (67.9) 0 (0) 0 (0)
Report given to primary-care physician 0 (0) 25 (4.5) 12 (2.4) 22 (4.0) 0 (0) 0 (0)
only 0 (0) 185 (33.5) 93 (18.6) 173 (31.4) 0 (0) 0 (0)
Report given to patient and primary-
care physician
0 (0) 4 (0.7) 2 (0.4) 6 (1.1) 0 (0) 0 (0)
Link with the Centre de santé et de
services sociaux Not applicable
0 (0) 28 (5.1) 232 (46.5) 36 (6.5) 0 (0) 0 (0)
aMore than one item could be checked.
bOther includes nutritionists (n = 16); pharmacy students (n = 5); and dieticians (n = 2).
cOther includes blood-pressure device available at the pharmacy (n = 9); pharmacy students (n = 8); nursing students (n = 3); and over-the-counter medications
salesperson (n = 1).
dOther includes pharmacy students (n = 6); nutritionist (n = 2); and dietician (n = 1).
eOther includes pharmacy students (n = 4); nutritionist (n = 3); over-the-counter medications salesperson (n = 2); nursing students (n = 1); and the patient in the
presence of the pharmacist (n = 1).
fOther includes pharmacy students (n = 3).
gOther includes pharmacy students (n = 1) and travel clinic at the pharmacy (n = 1).
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ing counseling when dispensing medications and referring
patients to external resources. When offered, such services
are provided relatively often and usually take 10 minutes
or less. There are several barriers that limit pharmacists’
involvement in health promotion and prevention, includ-
ing lack of time, lack of coordination with other health
care professionals, lack of staff or resources, lack of finan-
cial compensation, and lack of clinical tools.
Similarly to the present study, the results of a cross-
sectional mail survey of community pharmacists in British
Columbia published in 1994 showed that pharmacists are
mostly involved in activities directly related to the dispen-
sing or selling of medications and have less intense invol-
vement in health education and disease prevention [2]. A
1996 cross-sectional mail survey of community pharma-
cists practicing in the province of Quebec found that,
although only few pharmacists reported routinely per-
forming prevention activities, over 90% believed that inte-
grating prevention into their practices was important [1].
Similarly, a Web-based survey of pharmacists across
Canada reported that, although pharmacists currently
spend most of their time on dispensing duties, over 60%
believed it was time to assume new responsibilities, and
more than 70% wanted to expand their roles in various
fields including public health outreach (e.g. working with
communities and patients to focus on health promotion,
disease prevention and chronic disease management)
within five years [20]. Finally, a recent systematic review
on the beliefs and attitudes of pharmacists regarding phar-
maceutical public health showed that, although most view
public-health services as important and part of their role,
various organizational barriers limit their involvement
[21]. These results confirm the profession’s widespread
acceptance of community pharmacists’ changing role from
traditional dispensing duties to greater involvement in
health promotion and prevention and its understanding of
the importance of providing these services.
Evidently, pharmacists and the population at large would
welcome greater involvement of community pharmacies in
health-promotion and preventive services [21,22]. Our
results suggest that the development of future public-
health programs in community pharmacy should focus on
the continuity of care, maximizing the expertise of other
health care professionals who may be present in the phar-
macy, and overcoming organizational barriers. Such pro-
grams need to be well integrated within the primary-care
system through effective communication and collaboration
with other health care providers, and they should be sup-
ported by clinical tools, such as collective prescriptions, to
optimize the contribution of pharmacists.
In a study evaluating the impact of a community phar-
macy-based smoking cessation program in Northern Ire-
land, the involvement of pharmacies was especially low:
only 19% of recruited pharmacies enrolled the required
number of patients to participate in the study [7]. This is
in line with the results of the present study, suggesting
that although pharmacists may envision an ideal level of
involvement in health-promotion and preventive services,
this vision is often not translated into their actual practice.
In formal clinical trials where the level of involvement of
pharmacists in specific public-health activities may be con-
sidered as ideal, beneficial impacts have been identified,
namely in the area of smoking cessation [6,7], hyperten-
sion [9,10], dyslipidemia [9],d i a b e t e s[ 8 , 9 ] ,a n ds e x u a l
health [11]. Integrating primary-care pharmacists and
pharmacies into public-health programs should be consid-
ered a valuable option for optimizing population health. It
is therefore crucial to better understand the barriers and
facilitators of greater involvement of pharmacists in public
health activities.
Similarly again to our results, studies have identified key
barriers to the involvement of community pharmacists in
health promotion and prevention. They include the lack of
time, insufficient human resources, difficult access to
patients’ physicians, lack of skills and/or instrumentation,
lack of compensation for prevention acts, and lack of
space [1,23-25]. Other factors limiting the provision of
such activities in current practice that were found in the
literature but did not stand out in our study include the
general public’s lack of awareness of pharmacy’sr o l ei n
health promotion and prevention, lack of access to the full
patient record, confidentiality concerns, and defensive or
uncooperative patients [23-26]. It is therefore to be
expected that overcoming these barriers will require reor-
ganizing not only community-pharmacy practice but also
the health care system in order to better integrate pharma-
cists into the provision of preventive services. This reorga-
nization will doubtless require agreement, commitment
and engagement by all pharmacy stakeholders in addition
to financial investments.
Two studies have identified facilitators of practice
change in community pharmacy [27,28]. These factors
included government policy; remuneration for service
delivery; communication and teamwork; leadership; task
delegation; external support or assistance; reorganization
of the structure and function of the pharmacy; professional
satisfaction or competitiveness; communication and colla-
boration with physicians; and patient expectations regard-
ing the services to be offered. Future public-health
programs in community pharmacy will also need to con-
sider these factors in order to facilitate practice change.
This study has some limitations. No data were collected
regarding non-respondents; it is therefore possible that the
pharmacists who returned the completed questionnaire are
more motivated or interested than the non-respondents are
and that involvement in health promotion and prevention
may thus have been overestimated. A social-desirability
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Page 7 of 11Table 4 Specific activities conducted in health-promotion and preventive services in community pharmacies
a
Services Distribution of
written
information
n (%)
Personalized
counseling
when
Dispensing
medications
n (%)
Screening
b
n (%)
Referral to
external
resources
n (%)
Personalized follow-
up or private
consultation
n (%)
Other
n (%)
None
n
(%)
Lifestyle
Smoking cessation 386 (68.2) 509 (89.9) 193 (34.1) 283 (50.0) 252 (44.5) 44
(7.8)
c
0 (0)
Physical-activity promotion 154 (27.8) 349 (63.0) 20 (3.6) 169 (30.5) 23 (4.2) 9 (1.6)
d
51
(9.2)
Healthy eating 304 (54.0) 355 (63.1) 43 (7.6) 297 (52.8) 30 (5.3) 29
(5.2)
e
16
(2.8)
Weight management 150 (27.3) 277 (50.4) 42 (7.6) 257 (46.7) 23 (4.2) 25
(4.5)
f
72
(13.1)
Alcohol consumption 75 (13.6) 309 (56.1) 32 (5.8) 155 (28.1) 16 (2.9) 3 (0.5)
g
116
(21.1)
Dental health 47 (8.7) 180 (33.1) 13 (2.4) 262 (48.3) 7 (1.3) 4 (0.7)
h
159
(29.3)
Screening for:
Hypertension 344 (60.8) 480 (84.8) 417 (73.7) 186 (32.9) 304 (53.7) 35
(6.2)
i
6
(1.1)
Diabetes 364 (64.5) 489 (86.7) 351 (62.2) 246 (43.6) 254 (45.0) 33
(5.9)
j
8
(1.4)
Dyslipidemia 319 (57.1) 471 (84.3) 140 (25.0) 161 (28.8) 132 (23.6) 22
(3.9)
k
21
(3.8)
Risk of suicide 81 (15.1) 190 (35.4) 44 (8.2) 239 (44.6) 67 (12.5) 2 (0.4)
l
148
(27.6)
Sexual health
Emergency oral contraception 227 (40.2) 497 (88.0) 122 (21.6) 137 (24.2) 230 (40.7) 26
(4.6)
m
10
(1.8)
Contraception 214 (38.1) 510 (90.7) 58 (10.3) 220 (39.1) 105 (18.7) 2 (0.4)
n
11
(2.0)
Counseling with partners when
initiating treatment for sexually
transmitted diseases
111 (19.8) 488 (87.0) 36 (6.4) 166 (29.6) 51 (9.1) 0 (0) 30
(5.3)
Infectious diseases and immunization
Travel health 241 (43.0) 412 (73.4) 78 (13.9) 319 (56.9) 58 (10.3) 40
(7.1)
o
28
(5.0)
Needle exchange programs 91 (16.9) 163 (30.4) 34 (6.3) 117 (21.8) 14 (2.6) 67
(12.5)
p
189
(35.2)
Immunization programs 207 (37.3) 267 (48.1) 50 (9.0) 274 (49.4) 45 (8.1) 45
(8.1)
q
82
(14.8)
aMore than one item could be checked.
bScreening may be performed using a specific measure (e.g. blood-pressure measurement) and/or by documenting other risk factors (e.g. medication review,
interview with the patient).
cOther includes collective prescription (n = 39); health clinic at the pharmacy (n = 1); service offered by a nurse at the pharmacy (n = 1); oral presentations (n =
1); referral to the “iQuitnow” organization (n = 1); and answers to patients’ questions (n = 1).
dOther includes answers to patients’ questions (n = 5); service offered by a nurse at the pharmacy (n = 2); oral presentations (n = 1); and referral to a website (n
= 1).
eOther includes service offered by a nutritionist at the pharmacy (n = 13); counseling by a nurse at the pharmacy (n = 7); answers to patients’ questions (n = 4);
health clinic at the pharmacy (n = 3); referral to a website (n = 1); and distribution of Canada’s Food Guide (n = 1).
fOther includes service by a nurse at the pharmacy (n = 10); service by a nutritionist at the pharmacy (n = 7); answers to patients’ questions (n = 3); distribution
of Canada’s Food Guide (n = 1); referral to a website (n = 1); body-mass index measurement (n = 1); counseling on over-the-counter medications (n = 1); and
health clinic at the pharmacy (n = 1).
gOther includes answers to patients’ questions (n = 2) and referral to a website (n = 1).
hOther includes counseling on over-the-counter products (n = 2) and answers to patients’ questions (n = 2).
iOther includes service by a nurse at the pharmacy (n = 16); blood-pressure measurement at the pharmacy (n = 8); ambulatory blood pressure monitoring (n =
6); health clinic at the pharmacy (n = 3); “Tension Attention” program (n = 1); and follow-up with the physician (n = 1).
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Page 8 of 11bias may also have contributed to overestimate the ideal
and actual prevention practices. Finally, the length of the
questionnaire may have contributed to reduce the response
rate. Nonetheless, despite random sampling and the
absence of any telephone contact, the response rate was
relatively high. Moreover, comparison with statistics com-
piled by the OPQ on gender and pharmacist status showed
that our sample was representative of community pharma-
cists working in Quebec.
Conclusions
In conclusion, community pharmacists strongly believe
they should play a significant role in health promotion
and prevention. However, given the many organizational
barriers limiting their current public health activities, a
wide gap exists between their ideal and actual levels of
involvement.
Methods
Study design
In this cross-sectional study, a self-administered question-
naire was mailed to a random sample of 1,250 community
pharmacists practicing in Montreal and surrounding areas
from December 8, 2010, to February 23, 2011. The study
was approved by the Research Ethics Committee of the
Centre de santé et de services sociaux de Laval (Quebec,
Canada). As an incentive, each respondent was eligible for
a random draw of one of 10 prizes of $500.
Sampling procedures
Using the OPQ’s 2010 listing, which includes work-place
or home addresses, 1,887 community pharmacists were
identified in Montreal, Laval, Laurentides, Lanaudière,
Montérégie, Estrie, and Outaouais. Pharmacists working in
acute- and chronic-care hospitals or institutions are not
included in the list. A random sample of 1,250 pharmacists
weighted by the number of pharmacists in each region was
constituted: Montreal (n = 481 or 38.5%),
Laval (n = 119, 9.5%), Laurentides (n = 125, 10.0%),
Lanaudière (n = 103, 8.2%), Montérégie (n = 313, 25.0%),
Estrie (n = 64, 5.1%), and Outaouais (n = 45, 3.6%).
Mailings
A modified version of Dillman’s tailored design method
[29] was used to send the questionnaire to community
pharmacists. The procedure comprised: 1) a personalized
letter of invitation describing the study; 2) a first mailing
of the questionnaire one week after the invitation; 3) a
reminder postcard sent to non-respondents two weeks
after the first questionnaire mailing; 4) a second mailing of
the questionnaire to non-respondents two weeks after the
postcard; and 5) a third mailing of the questionnaire to
non-respondents three weeks after the second question-
naire mailing. Questionnaire mailings included a prepaid,
preaddressed return envelope.
Questionnaire
The questionnaire was written in French and is available
online [30]. The questionnaire was not translated in Eng-
lish because in Quebec, all pharmacy programs including
bridging programs for pharmacists from outside of Que-
bec are offered in French; all pharmacists in Quebec
must therefore read, write and speak French. It consisted
of 28 questions (in 11 pages plus a cover letter) and took
around 25 minutes to complete. These questions were
inspired by, but not restricted to, two previous question-
naires regarding the role of community pharmacists in
health education and disease prevention [1,26], and ques-
t i o n sw e r er e v i e w e df o rr e l e v a n c eb ya l la u t h o r s .T h e
questionnaire was pretested for comprehension, lan-
guage, relevance, and acceptability with a convenience
sample of five volunteer community pharmacists who
were not considered for participation in the study.
The first set of questions documented community
pharmacists’ ideal level of involvement in providing
health-promotion and preventive services. Pharmacists
Figure 1 Self-identified barriers to the provision of health-promotion and preventive services in current pharmacy practice
a.
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Page 9 of 11were then asked to indicate which services were actually
offered in their pharmacy, the employees involved, and
the frequency and duration of the services. Finally, we
documented their perceptions of the barriers to provid-
ing health-promotion and preventive services in com-
munity pharmacy and their opinion regarding the most
appropriate health professionals to provide them. We
also documented the characteristics of pharmacists,
pharmacies and their clientele.
Pharmacists working in more than one community
pharmacy were asked to refer to the one in which they
worked most of the time. Respondents’ characteristics
were compared with the characteristics reported for Que-
bec pharmacists in the OPQ’s annual report [31].
Statistical analyses
The characteristics of pharmacists and their community
pharmacies were described using means (and standard
deviations) for continuous variables and proportions for
discrete variables. For the questions on community phar-
macists’ role in health promotion and prevention and on
the barriers to the provision of such services, the propor-
tions of respondents selecting each possible answer were
computed. With a sample of 571 respondents, the margin
of error is estimated to be ± 4.1% 19 times out of 20,
assuming a probability of 50%. Analyses were performed
using SPSS software, version 19.0 (SPSS Inc., Chicago, IL).
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